Primary hyperparathyroidism – new clinical forms of the disease

Česká verzia

Authors: Kateřina Zajíčková
Authors place of work: Endokrinologický ústav, Praha
Published in the journal: Vnitř Lék 2017; 63(9): 604-608
Category: Reviews

Summary

Primary hyperparathyroidism (PHPT) has been increasingly diagnosed incidentally in its asymptomatic form owing to calcium screening tests. This form of PHPT represents 80% in developed countries. Although PHPT patients are asymptomatic, target organ (bone and kidney) involvement is frequently observed. Mild PHPT is associated with a reduction of bone mineral densityand, moreover, with increased risk of vertebral fractures. The extent of a patient evaluation and indications for parathyroidectomy are based on expert guidelines from 2014. Normocalcemic variant of PHPT has been recently recognized, possibly with higher prevalence in general population than the hypercalcemic form of PHPT. Normal but with respect to hypercalcemia inadequately high parathormon levels characterize normohormonal PHPT. If a hereditary form of PHPT is suspected, genetic testing is recommended. Although there are new clinical forms of PHPT, parathyroidectomy still represents the only curative approach to PHPT followed by substantial osteoprotective effect.

Key words:
asymptomatic form – normocalcemic form – normohormonal form – parathyroidectomy – primary hyperparathyroidism – recent guidelines for the management PHPT

Zdroje

1. Bilezikian JP, Cusano NE, Khan AA et al. Primary hyperparathyroidism. Nat Rev Dis Primers 2016; 2: 16033. Dostupné z DOI: <http://dx.doi.org/10.1038/nrdp.2016.33>.

2. Khan AA, Hanley DA, Rizzoli R et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 2017; 28(1): 1–19. Dostupné z DOI: <http://dx.doi.org/10.1007/s00198–016–3716–2>.

3. Parent X, Spielmann C, Hanser AM. “Corrected” calcium: calcium status underestimation in non-hypoalbuminemic patients and in hypercalcemic patients. Ann Biol Clin (Paris) 2009; 67(4): 411–418. Dostupné z DOI: <http://dx.doi.org/10.1684/abc.2009.0348>.

4. Ong GS, Walsh JP, Stuckey BG et al. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism. J Clin Endocrinol Metab 2012; 97(9): 3138–3145. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2012–1429>.

5. Bilezikian JP, Brandi ML, Eastell R et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3561–3569. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–1413>.

6. Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. J Clin Endocrinol Metab 2009; 94(2): 335–339. Dostupné z DOI: <http://dxdoi.org/10.1210/jc.2008–1763>.

7. Silverberg SJ, Clarke BL, Peacock M et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3580–3594.Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–1415>.

8. Cusano NE, Maalouf NM, Wang PY et al. Normocalcemic hyperparathyroidism and hypoparathyroidism in two community-based nonreferral populations. J Clin Endocrinol Metab 2013; 98(7): 2734–2741. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2013–1300>.

9. Šiprová H, Souček M, Fryšák Z et al. Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care – current issues. Vnitř Lék 2016; 62(10): 775–780.

10. Berger C, Almohareb O, Langsetmo L et al. Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers. Clin Endocrinol (Oxf) 2015; 82(3): 359–368. Dostupné z DOI: <http://dx.doi.org/10.1111/cen.12569>.

11. Eastell R, Brandi ML, Costa AG et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3570–3579.Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–1414>.

12. Applewhite MK, White MG, Tseng J et al. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery 2017; 161(1): 62–69. Dostupné z DOI: <http://dx.doi.org/10.1016/j.surg.2016.03.038>.

13. Udelsman R, Åkerström G, Biagini C et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99(10): 3595–3606. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–2000>.

14. Michaud L, Burgess A, Huchet V et al. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 2014; 99(12): 4531–4536. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–2821>.

15. Marcocci C, Bollerslev J, Khan AA et al. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocrinol Metab 2014; 99(10): 3607–3618. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–1417>.

16. Betea D, Potorac I, Beckers A. Parathyroid carcinoma: Challenges in diagnosis and treatment. Ann Endocrinol (Paris) 2015; 76(2): 169–177. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ando.2015.03.003>.

17. Giusti F, Cavalli L, Cavalli T et al. Hereditary hyperparathyroidism syndromes. J Clin Densitom 2013; 16(1): 69–74. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jocd.2012.11.003>.

18. Cromer MK, Starker LF, Choi M et al. Identification of somatic mutations in parathyroid tumors using whole-exome sequencing. J Clin Endocrinol Metab 2012; 97(9): E1774-E1781. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2012–1743>.

19. Iwata S, Walker MD, Di Tullio MR et al. Aortic valve calcification in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2012; 97(1): 132–137. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011–2107>.

20. Walker MD, McMahon DJ, Inabnet WB et al. Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 2009; 94(6): 1951–1958. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2008–2574>.

21. Verdelli C, Corbetta S. Mechanisms in endocrinology: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects. Eur J Endocrinol 2017; 176(1): R39-R52.